510(k) K933997

PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY by Alexon Biomedical, Inc. — Product Code GMD

K933997 is an FDA 510(k) premarket notification submitted by Alexon Biomedical, Inc. for the device "PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY". The FDA issued a decision of Substantially Equivalent on Nov 22, 1993. The device falls under product code GMD (Antisera, Latex Agglutination, Cryptococcus Neoformans), a Class II device regulated under 21 CFR 866.3165. Alexon Biomedical, Inc. has 4 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 22, 1993
Date Received
Aug 17, 1993
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Antisera, Latex Agglutination, Cryptococcus Neoformans
Device Class
Class II
Regulation Number
866.3165
Review Panel
MI
Submission Type
510(k) Exempt

Need the full FDA record for Alexon Biomedical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K933997. Report a data issue: hello@regdatalab.com.